Podcast

Dr. Katherine Rotker on destigmatizing sexual health

Author(s):

Urology Times staff

"I think there's a lot of fear that can go into talking about these topics," says Katherine Rotker, MD.

In this episode, Katherine Rotker, MD, discusses the stigmas surrounding sexual health and how clinicians can help address them with patients. Rotker is an assistant professor of urology at Yale School of Medicine in New Haven, Connecticut.

Related Videos
Ellen Cahill, MD, answers a question during a video interview
Male doctor examining patient | Image Credit: © Rawpixel.com - stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Ellen Cahill, MD, answers a question during a video interview
David Braun, MD, PhD, and Patrick Kenney, MD, answer questions during a video interview
Licensed FILE #: 458906503 Preview Crop Find Similar Expand Image DIMENSIONS 8000 x 5333px FILE TYPE JPEG CATEGORY The Environment LICENSE TYPE Standard or Extended A lake in the shape of a recycling sign in the middle of untouched nature | Image Credit: © malp - stock.adobe.com
Leslie Rickey, MD, MPH, answers a question during a video interview
Dr. Daniel Petrylak in an interview with Urology Times
Related Content
Breakthrough Study in Image-Guided Prostate Cancer Treatment
March 31st 2025

Breakthrough Study in Image-Guided Prostate Cancer Treatment

Yale School of Medicine
Published OPTIMUM Trial results compares high-resolution micro-ultrasound with MRI when considering prostate biopsy.
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Neoantigen cancer vaccine shows encouraging activity in ccRCC
Published: February 6th 2025 | Updated: February 6th 2025

Neoantigen cancer vaccine shows encouraging activity in ccRCC

Hannah Clarke
At a median follow-up of 40.2 months post-surgery, no patients had experienced a disease recurrence.
Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
February 21st 2025

Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Yale Urology’s First Female Professor
November 11th 2024

Yale Urology’s First Female Professor

Yale School of Medicine
"I hope this achievement serves as a positive example for young women...of what we can accomplish together!" says Leslie M. Rickey, MD, MPH.
Serum glycoproteins may predict response to nivolumab/cabozantinib in aRCC
September 16th 2024

Serum glycoproteins may predict response to nivolumab/cabozantinib in aRCC

Hannah Clarke
On Cox regression analysis, glycoproteins were predictive of PFS response to nivolumab plus cabozantinib vs sunitinib (P < .01).
© 2025 MJH Life Sciences

All rights reserved.